Kidney Cancer (Renal Cell Cancer) Global Clinical Trials Review, H2, 2012

121 views
106 views

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
121
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Kidney Cancer (Renal Cell Cancer) Global Clinical Trials Review, H2, 2012

  1. 1. Kidney Cancer (Renal Cell Cancer) Global Clinical TrialsReview, H2, 2012Report Details:Published:December 2012No. of Pages: 139Price: Single User License – US$2500Kidney Cancer (Renal Cell Cancer) Global Clinical Trials Review, H2, 2012SummaryGlobalDatas clinical trial report, “Kidney Cancer (Renal Cell Cancer) Global Clinical TrialsReview, H2, 2012" provides data on the Kidney Cancer (Renal Cell Cancer) clinical trial scenario.This report provides elemental information and data relating to the clinical trials on Kidney Cancer(Renal Cell Cancer). It includes an overview of the trial numbers and their recruitment status asper the site of trial conduction across the globe. The databook offers a preliminary coverage ofdisease clinical trials by their phase, trial status, prominence of the sponsors and also providesbriefing pertaining to the number of trials for the key drugs for treating Kidney Cancer (Renal CellCancer). This report is built using data and information sourced from proprietary databases,primary and secondary research and in-house analysis by GlobalDatas team of industry experts.Note: Certain sections in the report may be removed or altered based on the availability andrelevance of data for the indicated disease.Scope- Data on the number of clinical trials conducted in North America, South and Central America,Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, alongwith the clinical trial scenario in BRIC nations- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited andsponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)Reasons to buy- Understand the dynamics of a particular indication in a condensed manner
  2. 2. - Abridged view of the performance of the trials in terms of their status, recruitment, location,sponsor type and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or CompaniesGet your copy of this report @http://www.reportsnreports.com/reports/210604-kidney-cancer-renal-cell-cancer-global-clinical-trials-review-h2-2012.htmlMajor points covered in Table of Contents of this report includeTable of ContentsTable of Contents 2List of Tables 5List of Figures 7Introduction 8Kidney Cancer (Renal Cell Cancer) 8Report Guidance 8Clinical Trials by Region 9Clinical Trials by Country 10Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12Top Five Countries Contributing to Clinical Trials in Europe 13Top Countries Contributing to Clinical Trials in North America 14Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15Top Five Countries Contributing to Clinical Trials in Central and South America 16Clinical Trials by BRIC Nations 17Clinical Trials by G7 Nations 18Clinical Trials in G7 Nations by Trial Status 19Clinical Trials by E7 Nations 20Clinical Trials in E7 Nations by Trial Status 21Clinical Trials by Phase 22In Progress Trials by Phase 23Clinical Trials by Trial Status 24Unaccomplished Trials of Kidney Cancer (Renal Cell Cancer) 25Subjects Recruited Over a Period of Time 35Prominent Sponsors 36Top Companies Participating in Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials 38Prominent Drug Comparison 40Clinical Trial Profiles 41Clinical Trial Overview of Top Companies 41Pfizer Inc. 41Clinical Trial Overview of Pfizer Inc. 41Bayer AG 45Clinical Trial Overview of Bayer AG 45
  3. 3. GlaxoSmithKline plc 47Clinical Trial Overview of GlaxoSmithKline plc 47Novartis AG 49Clinical Trial Overview of Novartis AG 49Bristol-Myers Squibb Company 51Clinical Trial Overview of Bristol-Myers Squibb Company 51Eli Lilly and Company 52Clinical Trial Overview of Eli Lilly and Company 52Amgen Inc. 53Clinical Trial Overview of Amgen Inc. 53AVEO Pharmaceuticals, Inc. 54Clinical Trial Overview of AVEO Pharmaceuticals, Inc. 54Argos Therapeutics, Inc. 55Clinical Trial Overview of Argos Therapeutics, Inc. 55Pierre Fabre Medicament 56Clinical Trial Overview of Pierre Fabre Medicament 56Abbott Laboratories 57Clinical Trial Overview of Abbott Laboratories 57AstraZeneca PLC 58Clinical Trial Overview of AstraZeneca PLC 58Agenus, Inc. 59Clinical Trial Overview of Agenus, Inc. 59Genentech, Inc. 60Clinical Trial Overview of Genentech, Inc. 60Seattle Genetics, Inc. 61Clinical Trial Overview of Seattle Genetics, Inc. 61Hoffmann-La Roche Inc. 62Clinical Trial Overview of Hoffmann-La Roche Inc. 62F. Hoffmann-La Roche Ltd. 63Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 63Oxford BioMedica plc 64Clinical Trial Overview of Oxford BioMedica plc 64Celgene Corporation 65Clinical Trial Overview of Celgene Corporation 65Novartis Pharmaceuticals Corporation 66Clinical Trial Overview of Novartis Pharmaceuticals Corporation 66Clinical Trial Overview of Top Universities / Institutes / Hospitals 67Memorial Sloan Kettering Cancer Center 67Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 67The University of Texas M. D. Anderson Cancer Center 71Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 71UCLAs Jonsson Comprehensive Cancer Center 74
  4. 4. Clinical Trial Overview of UCLAs Jonsson Comprehensive Cancer Center 74Case Comprehensive Cancer Center 76Clinical Trial Overview of Case Comprehensive Cancer Center 76The University of Chicago 77Clinical Trial Overview of The University of Chicago 77Roswell Park Cancer Institute 78Clinical Trial Overview of Roswell Park Cancer Institute 78Beth Israel Deaconess Medical Center 79Clinical Trial Overview of Beth Israel Deaconess Medical Center 79Radboud University 80Clinical Trial Overview of Radboud University 80Barbara Ann Karmanos Cancer Institute 81Clinical Trial Overview of Barbara Ann Karmanos Cancer Institute 81Wake Forest University 82Clinical Trial Overview of Wake Forest University 82Fred Hutchinson Cancer Research Center 83Clinical Trial Overview of Fred Hutchinson Cancer Research Center 83Sarah Cannon Research Institute 84Clinical Trial Overview of Sarah Cannon Research Institute 84Mayo Clinic 85Clinical Trial Overview of Mayo Clinic 85Masonic Cancer Center 86Clinical Trial Overview of Masonic Cancer Center 86University Health Network 87Clinical Trial Overview of University Health Network 87Dana-Farber Cancer Institute 88Clinical Trial Overview of Dana-Farber Cancer Institute 88Fox Chase Cancer Center 89Clinical Trial Overview of Fox Chase Cancer Center 89Duke University 90Clinical Trial Overview of Duke University 90The Methodist Hospital System 91Clinical Trial Overview of The Methodist Hospital System 91University of California, San Francisco 92Clinical Trial Overview of University of California, San Francisco 92Five Key Clinical Profiles 93Appendix 136Abbreviations 136Definitions 136Research Methodology 137Secondary Research 137About GlobalData 138
  5. 5. Contact Us 138Disclaimer 138Source 139List of TablesKidney Cancer (Renal Cell Cancer) Therapeutics Market, Global, Clinical Trials by Zone, 2012* 9Kidney Cancer (Renal Cell Cancer) Therapeutics Market, Global, Clinical Trials by Top Countries,2012* 10Kidney Cancer (Renal Cell Cancer) Therapeutics Market, Global, Clinical Trials In Progress byTop Countries, 2012* 11Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries,2012* 12Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, Europe, Top Five Countries,2012* 13Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, North America, Top Countries,2012* 14Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, Middle East and Africa, Top FiveCountries, 2012* 15Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, Central and South America, TopFive Countries, 2012* 16Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, BRIC Countries, 2012* 17Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, G7 Countries, 2012* 18Kidney Cancer (Renal Cell Cancer) Therapeutics Market, G7 Countries, Clinical Trials by TrialStatus, 2012* 19Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, E7 Countries, 2012* 20Kidney Cancer (Renal Cell Cancer) Therapeutics Market, E7 Countries, Clinical Trials by TrialStatus, 2012* 21Kidney Cancer (Renal Cell Cancer) Therapeutics Market, Global, Clinical Trials by Phase, 2012*22Kidney Cancer (Renal Cell Cancer) Therapeutics Market, Global, Clinical Trials In Progress byPhase 2012* 23Kidney Cancer (Renal Cell Cancer) Therapeutics Market, Global, Clinical Trials by Trial Status,2012* 24Kidney Cancer (Renal Cell Cancer) Therapeutics Market, Global, Suspended Clinical Trials, 2012*25Kidney Cancer (Renal Cell Cancer) Therapeutics Market, Global, Withdrawn Clinical Trials, 2012*26Kidney Cancer (Renal Cell Cancer) Therapeutics Market, Global, Terminated Clinical Trials, 2012*28Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, Global, Average EnrollmentTarget Trends, 2006-2011 35Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 37
  6. 6. Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, Global, Top Companies byPhase, 2012* 39Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, Global, Clinical Trials byProminent Drugs, 2012* 40Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials byPfizer Inc., 2012* 41Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials byBayer AG, 2012* 45Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials byGlaxoSmithKline plc, 2012* 47Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials byNovartis AG, 2012* 49Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials byBristol-Myers Squibb Company, 2012* 51Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials byEli Lilly and Company, 2012* 52Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials byAmgen Inc., 2012* 53Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials byAVEO Pharmaceuticals, Inc., 2012* 54Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials byArgos Therapeutics, Inc., 2012* 55Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials byPierre Fabre Medicament, 2012* 56Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials byAbbott Laboratories, 2012* 57Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials byAstraZeneca PLC, 2012* 58Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials byAgenus, Inc., 2012* 59Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials byGenentech, Inc., 2012* 60Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials bySeattle Genetics, Inc., 2012* 61Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials byHoffmann-La Roche Inc., 2012* 62Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials byF. Hoffmann-La Roche Ltd., 2012* 63Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials byOxford BioMedica plc, 2012* 64Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials byCelgene Corporation, 2012* 65
  7. 7. Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials byNovartis Pharmaceuticals Corporation, 2012* 66Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials byMemorial Sloan Kettering Cancer Center, 2012* 67Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials byThe University of Texas M. D. Anderson Cancer Center, 2012* 71Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials byUCLAs Jonsson Comprehensive Cancer Center, 2012* 74Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials byCase Comprehensive Cancer Center, 2012* 76Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials byThe University of Chicago, 2012* 77Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials byRoswell Park Cancer Institute, 2012* 78Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials byBeth Israel Deaconess Medical Center, 2012* 79Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials byRadboud University, 2012* 80Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials byBarbara Ann Karmanos Cancer Institute, 2012* 81Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials byWake Forest University, 2012* 82Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials byFred Hutchinson Cancer Research Center, 2012* 83Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials bySarah Cannon Research Institute, 2012* 84Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials byMayo Clinic, 2012* 85Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials byMasonic Cancer Center, 2012* 86Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials byUniversity Health Network, 2012* 87Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials byDana-Farber Cancer Institute, 2012* 88Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials byFox Chase Cancer Center, 2012* 89Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials byDuke University, 2012* 90Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials byThe Methodist Hospital System, 2012* 91Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials byUniversity of California, San Francisco, 2012* 92
  8. 8. List of FiguresKidney Cancer (Renal Cell Cancer) Therapeutics Market, Global, Clinical Trials by Zone (%),2012* 9Kidney Cancer (Renal Cell Cancer) Therapeutics Market, Global, Clinical Trials by Top Countries,2012* 10Kidney Cancer (Renal Cell Cancer) Therapeutics Market, Global, Clinical Trials In Progress byTop Countries, 2012* 11Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries(%), 2012* 12Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, Europe, Top Five Countries (%),2012* 13Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, North America, Top Countries(%), 2012* 14Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, Middle East and Africa, Top FiveCountries (%), 2012* 15Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, Central and South America, TopFive Countries (%), 2012* 16Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, BRIC Countries (%), 2012* 17Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, G7 Countries (%), 2012* 18Kidney Cancer (Renal Cell Cancer) Therapeutics Market, G7 Countries, Clinical Trials by TrialStatus, 2012* 19Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, E7 Countries (%), 2012* 20Kidney Cancer (Renal Cell Cancer) Therapeutics Market, E7 Countries, Clinical Trials by TrialStatus, 2012* 21Kidney Cancer (Renal Cell Cancer) Therapeutics Market, Global, Clinical Trials by Phase (%),2012* 22Kidney Cancer (Renal Cell Cancer) Therapeutics Market, Global, Clinical Trials In Progress byPhase, 2012* 23Kidney Cancer (Renal Cell Cancer) Therapeutics Market, Global, Clinical Trials by Trial Status,2012* 24Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, Global, Average EnrollmentTarget Trends, 2006-2011 35Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 36Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, Global, Top Companies byPhase, 2012* 38Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, Global, Clinical Trials byProminent Drugs, 2012* 40GlobalData Methodology 137Contact: sales@reportsandreports.com for more information.

×